The γ‐Secretase Blocker DAPT Reduces the Permeability of the Blood–Brain Barrier by Decreasing the Ubiquitination and Degradation of Occludin During Permanent Brain Ischemia
- 22 November 2012
- journal article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 19 (1), 53-60
- https://doi.org/10.1111/cns.12032
Abstract
Tight junction protein degradation is a principal characteristic of the blood-brain barrier (BBB) damage that occurs during brain ischemia. We investigated the mechanisms of occludin degradation that underlie permanent middle cerebral artery occlusion (pMCAO) in rats. Western blot and Co-immunoprecipitation data indicated ubiquitination and degradation of occludin in brain after pMCAO, which was consistent with ZO-1 degradation in penumbra regions as observed at 24 h after pMCAO. We further investigated candidate protease(s) responsible for the degradation of occludin during pMCAO. The intraventricular administration of γ-secretase blocker DAPT significantly inhibited the pMCAO-induced neurovascular damage, whereas ALLM and Batimastat, which are inhibitors of calpain and metalloproteinase proteases, respectively, were less effective. Notably, we found that DAPT significantly inhibited BBB disruption in comparison with vehicle treatment, as assessed by Evans blue excretion. Interestingly, the confocal immunostaining revealed that activation of the E3 ubiquitin ligase Itch is associated with degradation of occludin in brain microvessels following ischemia. Furthermore, our data demonstrate that the inhibition of γ-secretase signaling and the itch-mediated ubiquitination of occludin likely underlie the vasoprotective effect of DAPT after pMCAO. The γ-secretase blocker DAPT reduces the permeability of the BBB by decreasing the ubiquitination and degradation of occludin during permanent brain ischemia, suggesting that γ-secretase may represent a novel therapeutic target for preventing neurovascular damage.Keywords
This publication has 39 references indexed in Scilit:
- α-Synuclein fate is determined by USP9X-regulated monoubiquitinationProceedings of the National Academy of Sciences of the United States of America, 2011
- The Proteome of Mouse Brain Microvessel Membranes and Basal LaminaJournal of Cerebral Blood Flow & Metabolism, 2011
- Association between adherens junctions and tight junctions via rap1 promotes barrier protective effects of oxidized phospholipidsJournal of Cellular Physiology, 2010
- Oxidative Stress Increases Blood–Brain Barrier Permeability and Induces Alterations in Occludin during Hypoxia–ReoxygenationJournal of Cerebral Blood Flow & Metabolism, 2010
- Neutrophil elastase and neurovascular injury following focal stroke and reperfusionNeurobiology of Disease, 2009
- Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial CellsJournal of Biological Chemistry, 2009
- VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdownProceedings of the National Academy of Sciences of the United States of America, 2009
- Inflammation and the neurovascular unit in the setting of focal cerebral ischemiaNeuroscience, 2009
- Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregatesNature, 2009
- Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotectiveNature Medicine, 2003